CANbridge Pharmaceuticals HK$685 million IPO
We advised CANbridge Pharmaceuticals on its IPO and HKEX listing
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
GrowthCurve Capital acquisition of Mistplay
We advised GrowthCurve Capital on the transaction
Riverbed Technology emerges from chapter 11 bankruptcy
We advised an ad hoc group of first-lien term lenders in connection with Riverbed’s restructuring
Avianca $1.05 billion DIP-to-exit financing
We advised an ad hoc group of investors on Avianca’s DIP-to-exit financing
Baker Hughes $1.25 billion notes offering
We advised Baker Hughes on the investment-grade debt offering
Encore Capital $300 million tender offer
The offer was structured as a modified “Dutch Auction” cash tender offer for common stock
Galaxy Digital $500 million exchangeable senior notes offering
We advised Galaxy Digital on its private placement of 3% exchangeable senior notes due 2026
Silvergate Capital $552 million follow-on offering
The shares are listed on the New York Stock Exchange
SS&C Technologies acquisition of Hubwise
We are advising SS&C Technologies on the transaction
KKR $750 million senior notes offering
The 3.25% investment-grade notes are due 2051